Clinical Trial Update: FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating FG001 in patients with meningioma or low-grade glioma is currently recruiting for neurosurgical studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma
• Meningioma

Drugs mentioned

• FG001

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Low-grade Glioma, Meningioma | Phase 2 | Status: RECRUITING